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Genome-wide association studies (GWAS) have now successfully identified important genetic variants associated with
many human traits and diseases. The high cost of genotyping arrays in large data sets remains the major barrier to wider
utilization of GWAS. We have developed a novel method in which whole blood from cases and controls, respectively, is
pooled prior to DNA extraction for genotyping. We demonstrate proof of principle by clearly identifying the associated
variants for eye color, age-related macular degeneration, and pseudoexfoliation syndrome in cohorts not previously
studied. Blood pooling has the potential to reduce GWAS cost by several orders of magnitude and dramatically shorten
gene discovery time. This method has profound implications for translation of modern genetic approaches to a multitude
of diseases and traits yet to be analyzed by GWAS, and will enable developing nations to participate in GWAS.
[Supplemental material is available online at http://www.genome.org. The sequence data from this study have been
submitted to Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession no. GSE17557.]
Genome-wide association studies (GWAS) have successfully iden-
tified single nucleotide polymorphisms (SNPs) associated with
many human diseases (McCarthy et al. 2008). GWAS have broken
a bottleneck in the understanding of common complex diseases as
no a priori knowledge of underlying molecular mechanisms is re-
quired (McCarthy et al. 2008). The high cost of SNP arrays remains
a major barrier to widespread utilization of such studies. Typically,
arrays capable of genotyping 33 105–13 106 SNPs are analyzed for
every case and control individually. GWAS generally utilize large
data sets with DNA extraction followed by SNP array genotyping
costs running to >US$1 million, accompanied by long-time re-
quirements for genotyping. Uncertainty about the genetic archi-
tecture of a given trait or disease means there is no guarantee of
a successful outcome despite the large investment required. Many
groups researching diseases in developing nations, or traits of
perceived lesser clinical significance, have been unable to pursue
GWAS methodology due to the high budgets required. One strat-
egy for reducing cost is equimolar pooling of separately extracted
DNA samples (Macgregor et al. 2006; Pearson et al. 2007). Rather
than individually genotyping each subject in the case and control
cohorts, stringently quantitated equimolar DNA pools derived
from all cases and all controls are constructed separately and then
genotyped. Pool construction for this genotyping strategy is labor-
intensive and requires sophisticated DNA quantitation procedures
(Macgregor et al. 2008).
We hypothesized that equal volume, but unquantitated
whole blood aliquots, from case and control cohorts could be
pooled prior to DNA extraction. Although this clearly introduces
a potential error relative to pooling of DNA, by deriving a formula
for the degree of error expected given typical cell count values, we
show that the additional error is very small. The ‘‘pooling of blood’’
(POB) method imparts large savings in time, labor, arrays, and re-
agents. We provide strong proof of principle data indicating that
POB-based GWAS can identify known genes for eye color, pseu-
doexfoliation syndrome, and for age-relatedmacular degeneration
(AMD), the commonest cause of blindness in the Western world.
The POB approach is easily applied to array-based GWAS, which
aim to identify common variants of small effect. However, with
full-genome sequencing becoming an accessible commodity, the
identification of rare causal variants of larger effect may also prove
tenable using our novel POB method.
Results
By pooling blood instead of DNA, individuals will not be equally
represented in the pool. In the Supplemental material we show
that the decrease in effective sample size of the pool is ;1 + c2,
where c is the coefficient of variation of the contribution of each
individual to the pool. The value of c is typically around 0.25 (Bain
1996). This implies that the decrease in effective sample size for
blood pooling, relative to DNA pooling, will only be;5%–6% and
that the results from POB will be broadly similar to those obtained
using DNA pooling and individual genotyping.
To test if our theoretical prediction that POB would be effec-
tive holds up in practice, 100mL aliquots of freshwhole bloodwere
pooled from 100 individuals with blue eyes and 100 people with
brown eyes, respectively. DNAwas then extracted (two extractions
in total, ;US$40) and array hybridization performed using Illu-
minaHumanHap550 SNP arrays. Concordance between POB allele
frequency estimates and individual reference frequencies was ex-
cellent, and even better between case and control pools (Fig. 1).
Tests of association revealed seven SNPs in the eye color study that
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achieved genome-wide significance (P < 53 108), all at theOCA2/
HERC2 locus (chromosome 15q11.2-q12), previously implicated in
eye color determination (Fig. 2A; Duffy et al. 2007; Sulem et al.
2007; Sturm et al. 2008). Multiple hits were also found in other
known pigmentation genes in the top 1000 associated SNPs: TYR,
TYRP1 and top 10,000: SLC24A4, SLC24A5 (see Supplemental Ta-
ble S1; Graf et al. 2007; Stokowski et al. 2007; Sulem et al. 2007).
To test whether fresh blood is a requirement for successful
POB, a second case-control cohort was studied in which whole
blood had been stored at 4°C for >12 mo. Previous studies of AMD
have identified two major susceptibility loci; CFH (chromosome
1q32) and ARMS2/HTRA1 (chromosome 10q25-q26) (Edwards
et al. 2005; Hageman et al. 2005; Klein et al. 2005; Dewan et al.
2006; Yang et al. 2006; Fritsche et al. 2008). We used a modified
POB protocol (Supplemental material) to construct a pool from
131 cases of exudative AMD and another from 216 examined
normal controls. These samples were hybridized on Illumina 1M
arrays. The association of exudative AMD with the CFH gene was
easily detected (Fig. 2B) with multiple SNPs in the most strongly
associated region. The ARMS2/HTRA1 locus also appeared in the
top 10 associated SNPs (Table 1; Supplemental material).
In the third POB GWAS, which utilized data generated from
the same control cohort, and a fresh POB sample from100 patients
with pseudoexfoliation syndrome, we easily identified the LOXL1
gene, which has been recently associatedwith this disease (Fig. 2C;
Thorleifsson et al. 2007; Hewitt et al. 2008).
Estimation of pooling error
Pooling allele frequency estimates are known to be most useful in
estimating differences in frequency between pools rather than
absolute frequencies (Macgregor et al. 2006), on account of the
potential unequal amplification of alleles at some SNPs. To a close
approximation, any unequal amplification effects cancel when
frequency differences are used, partly explaining the higher con-
cordance seen in Figure 1A compared with Figure 1B.
Pooling error was assessed for the AMD pools (Illumina 1M
arrays). The variation in the difference in pooling allele frequency
estimates between the case and control pools was compared with
what would be expected if pools of this size were individually
genotyped. If either the number of individuals contributing to the
pooling allele frequency estimate was lower than that specified/
expected (e.g., due to some individuals contributing substantially
more DNA than other individuals) or the array specific error was
high, then the variation in the difference in pooling allele fre-
quency would be unusually high. Using the previously described
method (Macgregor et al. 2006), an explicit estimate of the pooling
variance resulted in an estimate of 6.8 3 105. This estimate
comprises both error due to pool construction (here attributable to
unequal contributions of cells from different individuals and to
pipetting or measurement error) and due to array probe. This es-
timate is similar to that observed in previous DNA pool studies
using Illumina HumanHap arrays, validating our theoretical cal-
culation comparing POB and DNA pooling. Although our theo-
retical calculation focused on variation due to unequal WBC
counts, other variation in total DNA yield (including that caused
by potential degradation of samples in our refrigerator stored AMD
data set) per person must have been small for us to have obtained
this small estimate. The estimate of 6.8 3 105 is 5–10 times
smaller than the variance due to random sampling of individuals
from the population (for fuller discussion, see Macgregor 2007;
Macgregor et al. 2008). The arrays used here (1M) differed from
those we have reported previously (Macgregor et al. 2008;
HumanHap300), but HumanHap300 and 1M arrays have similar
arrangements of beadscores on the arrays so similar performance
for different array types is expected. In Macgregor et al. (2008),
three arrays were used for each (equal sized) pool, which should
give similar array specific variance as the arrangement used here
(two and six arrays forN = 131 AMD case andN = 216 control pool,
respectively). Different numbers of case and control pool arrays
were used because there were different numbers of individuals in
the two pools. The low estimates of pooling error using this
methodology implies that disease associated variants of small ef-
fect sizewill be identifiable using adequately powered large cohorts
of cases and controls. Such estimates of pooling error imply an
Figure 1. (A) Comparison in allele frequency between 540 individually genotyped Caucasian reference samples compared to the 216 control POB
samples. (B) Correlation between estimated allele frequencies in the POB AMD case and control subjects. (A,B) A subset of 1000 randomly chosen SNPs are
plotted, with the broken gray line being y = x and the solid gray line the regression line for the full set of SNPs. The reduced correlation in A is due to the
unequal amplification of alleles (see main text for discussion).
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effective relative sample size (Macgregor et al. 2006) of ;90%
for the AMD case-control sample. This suggests that, consistent
with DNA pooling results from larger pools (Brown et al. 2008;
Macgregor et al. 2008), POB will prove useful for detecting smaller
effect sizes in larger pools. In contrast to up-scaling individual or
equimolar DNA pooling strategies to much larger data sets, with
blood pooling the budget remains very low irrespective of the
sample size.
Discussion
Using the novel POB method we identified the associations be-
tween previously identified genes in all three separate GWAS. Im-
portantly, the individual allelic architecture of these three case-
control cohorts had not been previously determined. Despite the
extreme simplicity of the underlying hypothesis and method,
estimates of pooling error in these cohorts were remarkably small
relative to random sampling error. A plethora of human diseases
and traits warrant genome-wide investigation, and it is foreseen
that POB prior to DNA extraction will both broaden access to this
cutting edge modality and expedite disease-gene discovery. For
novel findings, additional replication cohorts will be required as
for any properly conducted GWAS.
The dramatic reduction in costs and time required for GWAS
using the POB technique has profound implications for genetics
research. It is especially noteworthy that application of this meth-
odology would also allow larger GWAS to be cheaply performed
(Fig. 3). A conventional individual genotyping experiment on 2000
Figure 2. (A) Identification of theOCA2/HERC2 eye color locus (15q11.2-q12) using POB GWAS. Horizontal line at P = 53 108 indicates genome-wide
significance. Multiple significant SNP associations were also found in other known pigmentation loci in the top 1% of genotyped SNPs (TYR, TYRP1,
SLC24A4, and SLC24A5). (B) Age-related macular degeneration POB GWAS. SNPs at the CFH locus (1q32) clearly reached genome-wide significance. SNP
rs10922153 in CFHR5 adjacent to CFHwas also strongly associated P = 6.93 109. SNP rs3750847 in ARMS2/HTRA1 (10q25-q26) yielded P = 6.43 108.
(C ) Pseudoexfoliation syndrome POB GWAS. Strong association of SNPs at the LOXL1 locus (15q22), where two SNPs (rs8041642, rs2165241) reached
genome-wide significance.
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cases and 2000 controls would cost ;US$1.8 million and take
several months to perform. This GWAS would typically be the ex-
pensive first stage in amultiple stage design examining twoormore
data sets. In contrast, a POB experiment could yield similar first-
stage results in a few weeks for ;US$15,000. Since POB perfor-
mance was broadly similar to DNA pooling performance, previous
cost benefit calculations for the allocation of resources in pooling-
based multistage designs (Macgregor et al. 2008) remain valid.
The simplicity and robustness of our method will expedite
scientific discovery, laying open the field of genome-wide associ-
ation to smaller research groups, and to answer biological ques-
tions that would otherwise not be asked. Our described method-
ology is directly applicable to researchers in the developing world,
as well as investigators not previously involved in genetics work.
We also foresee that the pooling of blood samples could enable the
discovery phase of initial GWAS to be performed rapidly and
cheaply with positive results followed up
in previously established cohorts. A rela-
tive disadvantage of POB is that since it is
not necessary to extract DNA from each
individual sample, then DNA would not
be available for subsequent individual
genotyping. Clearly, the lack of stored
DNA from each individual included in
the blood pools does not permit in-
dividual genotyping in stage two of
analysis. However, given the low pooling
error we demonstrate here with POB,
most of the available information is
extracted from the POB samples (e.g.,
expressed in terms of effective relative
sample size; Macgregor et al. 2008) and further resources would be
best spent on genotyping the implicated SNPs in independent
replication samples. Furthermore, in the event of positive results,
DNA can be extracted later from stored blood samples if deemed
worthwhile.
There are several established analytical restrictions with
equimolar DNA pools that are also applicable to POB. It must be
noted that any quality control step or analysis that requires
individual-level genotypes cannot be performed using current
pooling methods, including POB. This includes haplotype con-
struction, SNP imputation and analysis of case-control status,
while adjusting for covariates (Homer et al. 2008a; Jawaid and
Sham 2008). Additionally, poorly performing individual samples
and bias due to population stratification are not easily controlled;
however, they may be overcome by pooling design (Sham et al.
2002). Nonetheless, novel statistical methods are continually
Table 1. AMD pooling of blood results for the top 10 associated SNPs
SNP Chromosome
Physical
position
Associated
allele Case Control CEU P-value
Nearest
gene
rs10801555 1 194926884 A 0.64 0.38 0.39 2.47 3 1010 CFH
rs1329428 1 194969433 T 0.21 0.43 0.41 9.13 3 1010 CFH
rs12789105 11 129609463 A 0.92 0.75 0.93 2.01 3 109 ZBTB44
rs10922153 1 195245238 T 0.29 0.52 0.44 6.77 3 109 CFHR5
rs12038333 1 194939077 A 0.36 0.59 0.61 7.17 3 109 CFH
rs1872887 11 45071998 T 0.39 0.18 0.10 2.14 3 108 PRDM11
rs12037583 1 173859928 T 0.13 0.31 0.06 2.74 3 108 TNR
rs1859281 12 46502016 A 0.05 0.18 0.11 4.02 3 108 VDR
rs3750847 10 124205411 T 0.46 0.25 0.22 6.40 3 108 HTRA1
rs11960097 5 120452561 T 0.72 0.90 0.89 6.98 3 108 PRR16
Figure 3. Flowchart comparing available options for performing genome-wide association studies. Costs and time calculations were based on
experiments with 2000 cases and 2000 controls.
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being developed for genome-wide imputation and haplotype-
based analysis of pooled data (Kirkpatrick et al. 2007; Homer et al.
2008b; Zhang et al. 2008). It is also worthwhile noting that given
such a small number of arrays are required it is possible to usemore
expensive state-of-the-art arrays with a larger number of SNPs in
pooling studies. In such cases (e.g., when using the 1 million SNP
Illumina arrays on Caucasian samples), the need for imputation is
diminished because a larger number of SNPs are genotyped di-
rectly. Another important limitation of this methodology is that
the lack of individual-level data limits the study to a single phe-
notype for each constructed pool, even if many more phenotypes
were recorded. The lack of individual genotype data and, in turn,
the inability for covariate adjustment, decreases the power of
pooling-based GWA studies. Additionally, copy number variants
are difficult to quantify, and cannot be currently analyzed.
Further development of this POB methodology could be di-
rectly applied to diverse fields, such as animal trait mapping, or be
transferable to other array-based technologies, such as those emerg-
ing in the fields of proteomic and epigenetics research (Kendziorski
et al. 2005; Docherty et al. 2009), or even newer generation se-
quencing techniques (Shendure and Ji 2008). Perhaps the greatest
benefit to flow from the described methodology will be the oppor-
tunity for clinicians and researchers in the developing world to
participate in the GWAS biological revolution.
Methods
Subject recruitment and DNA extraction
All participants provided written informed consent for this study,
which was approved by The Flinders Medical Center Human Re-
search Ethics Committee. Venous blood samples from Caucasian
individuals with blue eyes (n = 100), brown eyes (n = 100), and
pseudoexfoliation (n = 100), were collected in 9-mL EDTA tubes.
One-hundred-microliter aliquots of whole blood from each of the
100 individuals in each groupwere combined after gentle agitation
into three 10-mL pools of blood (POB). Whole blood samples,
which had been stored at 4°C for between 12 and 24mo, from 131
Caucasian patients with exudative AMD and 216 examined
disease-free Caucasian controls, were also pooled following lysis of
each individual sample to improve homogeneity of the stored
samples. Genomic DNA was extracted from each blood pool
according to manufacturer guidelines using the QIA-AMP DNA
blood maxi kit (QIAGEN). The extracted DNA was quantified by
spectrophotometry.
Generation and analysis of array data
The blue and brown eye color pools were hybridized to two Illu-
mina HumanHap550 duo arrays (Illumina), as reference samples
are readily available for these arrays (Schymick et al. 2007). The
pools were configured to each appear once on each of the two duo
arrays, resulting in raw data in the same format as if two replicate
single-sample arrays had been used on each pool. The AMD case
pools were genotypedwith two (single sample) Illumina 1Marrays,
the pseudoexfoliation case pools with four Illumina 1Marrays, and
the larger control pool genotyped with six Illumina 1M arrays.
Bead-level intensity data were analyzed. SNPs with beadscore
values <50 were excluded. Copy number variants and SNPs from
the sex chromosomes were not analyzed. SNPs were also removed
in the initial quality control if they had a minor allele frequency
<1% in the HapMap CEU reference samples.
Beadscores required calibration because green beadscores
tended to be larger than red beadscores. Illumina HumanHap550
arrays had 10 stripes (previously denoted as ‘‘strands’’ [Macgregor
et al. 2008]) per array, eachwith;55,000 SNPs. Illumina 1M arrays
had 20 stripes per array, each with ;50,000 SNPs. Within each
stripe, half of the SNPs were from the Illumina ‘‘TOP’’ strand (A/C
and A/G SNPs) and half were from the Illumina ‘‘BOTTOM’’ strand
(T/C and T/G SNPs). The pooling allele frequency (PAF) was com-
puted as the corrected red intensity divided by the total (corrected
red plus green) intensity. Normalization was performed within
stripe, separately for each strand by rescaling the red beadscore to
make the mean PAF value = 0.5 (for all SNPs on that stripe/strand).
A very small number of SNPs had <5 PAF estimates available and
were dropped. SNPs were removed from the analysis if they had
a log10(P) quality control value >6. SNPs from different strands
exhibited different levels of pooling error; hence, 261,887
(HumanHap550) and 375,246 (1M) SNPs from the BOTTOM
strand are presented.
After correction for green/red ratio variability, a linear model
was used to test for allelic association in which the PAF estimate for
each SNP was the response variable. A test statistic that corrected
for the pooling error was used to rank SNPs, with P-values based on
a x2 distribution with 1 degree of freedom (Macgregor et al. 2006).
Since this method is based upon contrasting case and control
pools, the effect of unequal amplification of alleles is minimal as
such effects cancel out (Macgregor et al. 2006, 2008). Using a pre-
viously described method (Macgregor et al. 2008), the explicit es-
timate of pooling variance in the AMD experiment was 6.83 105,
similar to that observed with previous equimolar DNA pools.
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